Join to View Full Profile
4502 Medical DriveSan Antonio, TX 78229
Phone+1 210-358-4000
Fax+1 210-567-4670
Dr. Ho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Tony Ho is an Infectious Disease specialist based in San Antonio, TX. He completed his medical education at the Texas Tech University Health Sciences Center School of Medicine in 2007, followed by an Internal Medicine residency and an Infectious Disease fellowship at the University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine. His research has been published in reputable journals such as The Journal of Antimicrobial Chemotherapy and Diagnostic Microbiology and Infectious Disease, with notable works on MRSA bacteraemia and endocarditis, and immune reconstitution inflammatory syndrome.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Infectious Disease, 2010 - 2012- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2007 - 2010
Texas Tech University Health Sciences Center School of MedicineClass of 2007
Certifications & Licensure
TX State Medical License 2011 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 110 citationsMethicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapyTony T. Ho, Jose Cadena, Lindsey M. Childs, Miguel Gonzalez-Velez, James S. Lewis
The Journal of Antimicrobial Chemotherapy. 2012-05-01 - 25 citationsImmune reconstitution inflammatory syndrome after cessation of the tumor necrosis factor α blocker adalimumab in cryptococcal pneumoniaJose Cadena, George Richard Thompson, Tony T. Ho, Edward A. Medina, Darrel W. Hughes
Diagnostic Microbiology and Infectious Disease. 2009-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
